View this email in your browser
You are receiving this email because of your relationship with BioXcel Corporation. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
Sign Up Now
Receive your personal complimentary copy of our
In-depth R&D and Commercial Analyses

PharmGPS® Insights, is an Industry Newsletter that is a MUST read for any Biopharma Executive! Fortnightly issues offer high quality industry intelligence from PharmGPS, a big data analytics and deep machine learning based artificial intelligence platform, that provides a real-time snapshot of emerging pipeline therapies for indications across all major therapeutic areas. Track competitors, identify partners, evaluate opportunities, formulate business development strategies, and execute in-licensing & out-licensing deals, and more with PharmGPS.

PharmGPS® Hotspot, a breaking news publication, is born from the premise that all our industry professionals need immediate information on hot topics as and when they happen! Hotspot provides you with the big splash news from the industry and more importantly, direction on what it all means, and how you can stay ahead of the curve!

Interested in Celiac Disease?
We have it covered in the next issue of Insights which will be
available on November 29th!
PharmGPS is a registered trademark of BioXcel Corporation
This message was sent to pharmgpsinsights@bioxcel.com by pharmgpsinsights@bioxcel.com
BioXcel Corporation, 780 East Main Street, Branford, CT, 06405


Unsubscribe from all mailings Unsubscribe | Manage Subscription | |


This is a Test Email only.
This message was sent for the sole purpose of testing a draft message.